TriSalus Life Sciences, Inc.: ceo and president Mary T Szela sold 2,693 shares

What happened The Form 4 reports that Mary T Szela, CEO and president and director, had 2,693 shares withheld to satisfy tax withholding in connection with the vesting of restricted stock units; the filing lists a per-share value of $4.38 and a total of $11,795 on Oct 5, 2026.

Key details

• Transaction date and price: Oct 5, 2026 — 2,693 shares at $4.38 per share (total $11,795); transaction code F (tax withholding).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote: F1 — represents shares withheld by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units previously granted.
• Filing date: Oct 7, 2026.

Why it may matter

• The Form 4 shows this was a tax-withholding event (code F): shares were withheld by the issuer to cover tax obligations tied to RSU vesting rather than reported as a cash market sale.
  A filing does not show why the insider traded or why the company acted.